Persistence of gene expression profile in CD200 transgenic skin allografts is associated with graft survival on retransplantation to normal recipients

Transplantation

Volumn 94, Issue 1, 2012, Pages 36-42

  Yu, Kai ^a   Gorczynski, Reginald M ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

CD200; Secondary transplantation; Tolerance induction

Indexed keywords

CD200 ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 35; MESSENGER RNA; PROGRAMMED DEATH 1 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FOXP3 GENE; GENE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GRAFT RECIPIENT; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; INTERLEUKIN 10 GENE; IRRADIATION; LYMPHOCYTE DIFFERENTIATION; MALE; MIXED LEUKOCYTE CULTURE; MOUSE; NONHUMAN; PD 1 GENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETRANSPLANTATION; SKIN ALLOGRAFT; SKIN TRANSPLANTATION; SPLEEN CELL; TRANSFORMING GROWTH FACTOR BETA GENE; TRANSGENICS;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; GENE EXPRESSION PROFILING; GRAFT SURVIVAL; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; REOPERATION; SKIN TRANSPLANTATION; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HOMOLOGOUS;

EID: 84863728642     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318257ad5c     Document Type: Article

References (28)

1. Francis RS, Feng G, ThaIn T, et al. Induction of transplantation tolerance converts potential effector T cells into graft-protective regulatory T cells. Eur J Immunol 2011; 41: 726.
2. Kendal AR, Waldmann H. Infectious tolerance: therapeutic potential. Curr Opin Immunol 2010; 22: 560.
3. Gorczynski RM. Thymocyte/splenocyte-derived CD4+CD25+ Treg stimulated by anti-CD200R2 derived dendritic cells suppress MLCs and skin graft rejection. Transplantation 2005; 81: 1027.
4. Kai G, Chen Z, Yang S, et al. Decreased alloreactivity using donor cells from mice expressing a CD200 transgene under control of a tetracyclineinducible promoter. Transplantation 2005; 80: 394.
5. Gorczynski R,Chen ZQ,Kai Y, et al. CD200 is a ligand for allmembers of the CD200R family of immunoregulatory molecules. J Immunol 2004; 172: 7744.
6. Gorczynski RM, Chen ZQ, He W, et al. Expression of a CD200 transgene is necessary for induction but not maintenance of tolerance to cardiac and skin allografts. J Immunol 2009; 183: 1560.
7. Gorczynski RM, Chen Z, Khatri I, et al. Graft-infiltrating cells expressing a CD200 transgene prolong allogeneic skin graft survival in association with local increases in Foxp3+Treg and mast cells. Transpl Immunol 2011; 25: 187.
8. Lu LF, Lind EF, Gondek DC, et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006; 442: 997.
9. Millan O, Benitez C, Guillen D, et al. Biomarkers of immunoregulatory status in stable liver transplant recipients undergoing weaning of immunosuppressive therapy. Clin Immunol 2010; 137: 337.
10. Xu J, Wang D, Zhang C, et al. Alternatively expressed genes identified in the CD4(+) T cells of allograft rejection mice. Cell Transplant 2011; 20: 333.
11. Koksoy S, Elpek KG, Yolcu ES, et al. Tolerance to rat heart grafts induced by intrathymic immunomodulation is mediated by indirect recognition primed CD4+ CD25(+) T-reg cells. Transplantation 2005; 79: 1492.
12. Hall BM, Plain KM, Verma ND, et al. Transfer of allograft specific tolerance requires CD4(+)CD25(+)T cells but not interleukin-4 or transforming growth factor-beta and cannot induce tolerance to linked antigens. Transplantation 2007; 83: 1075.
13. Iwase H, Kobayashi T, Kodera Y, et al. Clinical significance of regulatory T-cellYrelated gene expression in peripheral blood after renal transplantation. Transplantation 2011; 91: 191.
14. Wan YY, Flavell RA. TGF-beta and regulatory T cell in immunity and autoimmunity. J Clin Immunol 2008; 28: 647.
15. Boudakov I, Liu J, Fan N, et al. Mice lacking CD200R1 show absence of suppression of lipopolysaccharide-induced tumor necrosis factoralpha and mixed leukocyte culture responses by CD200. Transplantation 2007; 84: 251.
16. Wan YSY, Flavell RA. The roles for cytokines in the generation and maintenance of regulatory T cells. Immunol Rev 2006; 212: 114.
17. Yu K, Chen Z, Khatri I, et al. CCR4 dependent migration of Foxp3+ Treg cells to skin grafts and draining lymph nodes is implicated in enhanced graft survival in CD200tg recipients. Immunol Lett 2011; 141: 116.
18. Xiao H, Wang S, Miao RS, et al. TRAIL is associated with impaired regulation of CD4(+)CD25(j) T cells by regulatory t cells in patients with rheumatoid arthritis. J Clin Immunol 2011; 31: 1112.
19. Bucher P, Mai G, Mathe Z, et al. Retransplantation of discordant xenogeneic islets with costimulatory blockade. Transplant Proc 2004; 36: 1201.
20. Verbinnen B, Billiau AD, Vermeiren J, et al. Contribution of regulatory T cells and effector T cell deletion in tolerance induction by costimulation blockade. J Immunol 2008; 181: 1034.
21. Hall BM, Tran G, Hodgkinson SJ. Alloantigen specific T regulatory cells in transplant tolerance. Int Immunopharmacol 2009; 9: 570.
22. Okumi M, Fishbein JM, Griesemer AD, et al. Role of persistence of antigen and indirect recognition in the maintenance of tolerance to renal allografts. Transplantation 2008; 85: 270.
23. Degauque N, Mariat C, Kenny J, et al. Regulation of T-cell immunity by T-cell immunoglobulin and mucin domain proteins. Transplantation 2007; 84: S12.
24. Matteoli G, Mazzini E, Iliev ID, et al. Gut CD103(+) dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction. Gut 2010; 59: 595.
25. Lu L, Yu Y, Li GQ, et al. CD8(+)CD103(+) regulatory T cells in spontaneous tolerance of liver allografts. Int Immunopharmacol 2009; 9: 546.
26. Zheng SG, Meng LZ, Wang JH, et al. Transfer of regulatory T cells generated ex vivo modifies graft rejection through induction of tolerogenic CD4+CD25+ cells in the recipient. Int Immunol 2006; 18: 279.
27. Lob S, Konigsrainer A. Role of IDO in organ transplantation: promises and difficulties. Int Rev Immunol 2009; 28: 185.
28. Chaturvedi V, Collison LW, Guy CS, et al. Cutting edge: human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J Immunol 2011; 186: 6661.